Found 21 matching trials
Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB) PHASE2 This study is an evaluation of the short term effects on CNV perfusion of a...
Show More Location
Klinik und Poliklinik fuer Augenheilkunde, Inselspital
Learn More & Join Trial
Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) PHASE2 This study will evaluate the effect of combination therapy with verteporfin...
Show More Location
Novartis Investigative site
Learn More & Join Trial
Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia PHASE1 To demonstrate the efficacy of ranibizumab in combination with reduced-flue...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization PHASE2 The purpose of this study is to compare the efficacy of photodynamic therap...
Show More Location
Centro Medico Isemmym
Learn More & Join Trial
Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration PHASE4 In this pilot study the researchers will evaluate the safety and efficacy o...
Show More Location
Eagle Mountain Vision
Learn More & Join Trial
Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis PHASE2 The purpose of this study is to evaluate the change in visual activity of r...
Show More Location
Macula-Retina-Vitreous Service, Midwest Eye Institute
Learn More & Join Trial
Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD) PHASE1 The primary purpose of this study is to determine if injections of rhuFab V...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy PHASE4 This study aims to compare the efficacy of ranibizumab and verteporfin PDT ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration PHASE2 The purpose of this study is to compare triple therapy using Photodynamic t...
Show More Location
Bay Area Retina Associates
Learn More & Join Trial
Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-related Macular Degeneration (AMD) NA The purposes of this study is to determine if combination reduced fluence p...
Show More Location
Multiple Locations
Learn More & Join Trial